机器学习算法评估成人先天性心脏病预后并指导治疗:单中心10019例患者数据
中位随访8年785例死亡,自动推导的疾病严重度评分与生存独立相关。
要点
- 深度学习模型可高准确率分类诊断、疾病复杂度和NYHA分级。
- 模型可预测患者是否需要多学科团队讨论,准确率90.2%。
- 自动推导的疾病严重度评分与生存独立相关。
核心结论
- 基于大数据的深度学习算法可用于成人先天性心脏病患者的预后评估并可能指导治疗。
主要发现
- 测试样本中诊断分类准确率91.1%,疾病复杂度分类准确率97.0%,NYHA分级准确率90.6%。
- 多学科团队讨论需求的预测准确率为90.2%。
- 中位随访8年期间785例患者死亡,自动推导的疾病严重度评分在Cox分析中与生存独立相关(校正人口学、运动、实验室和心电图参数后)。
临床怎么用
- 深度学习算法可辅助成人先天性心脏病患者的预后评估和多学科团队讨论决策。
- 算法 largely 自动化,可扩展至多机构数据集以进一步优化并作为在线决策工具。
局限性
- 研究为单中心数据,模型外部验证不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To assess the utility of machine learning algorithms on estimating prognosis and guiding therapy in a large cohort of patients with adult congenital heart disease (ACHD) or pulmonary hypertension at a single, tertiary centre. METHODS AND RESULTS: We included 10 019 adult patients (age 36.3 ± 17.3 years) under follow-up at our institution between 2000 and 2018. Clinical and demographic data, ECG parameters, cardiopulmonary exercise testing, and selected laboratory markers where collected and included in deep learning (DL) algorithms. Specific DL-models were built based on raw data to categorize diagnostic group, disease complexity, and New York Heart Association (NYHA) class. In addition, models were developed to estimate need for discussion at multidisciplinary team (MDT) meetings and to gauge prognosis of individual patients. Overall, the DL-algorithms-based on over 44 000 medical records-categorized diagnosis, disease complexity, and NYHA class with an accuracy of 91.1%, 97.0%, and 90.6%, respectively in the test sample. Similarly, patient presentation at MDT-meetings was predicted with a test sample accuracy of 90.2%. During a median follow-up time of 8 years, 785 patients died. The automatically derived disease severity-score derived from clinical information was related to survival on Cox analysis independently of demographic, exercise, laboratory, and ECG parameters. CONCLUSION: We present herewith the utility of machine learning algorithms trained on large datasets to estimate prognosis and potentially to guide therapy in ACHD. Due to the largely automated process involved, these DL-algorithms can easily be scaled to multi-institutional datasets to further improve accuracy and ultimately serve as online based decision-making tools.
引用
- Diller GP, Kempny A, Babu-Narayan SV, et al. Machine learning algorithms estimating prognosis and guiding therapy in adult congenital heart disease: data from a single tertiary centre including 10 019 patients. Eur Heart J. 2019. PMID: 30689812. doi:10.1093/eurheartj/ehy915
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。